Abstract: The present application provides nitride semiconductor nanoparticles, for example nanocrystals, made from a new composition of matter in the form of a novel compound semiconductor family of the type group II-III-N, for example ZnGaN, ZnInN, ZnInGaN, ZnAlN, ZnAlGaN, ZnAlInN and ZnAlGaInN. This type of compound semiconductor nanocrystal is not previously known in the prior art. The invention also discloses II-N semiconductor nanocrystals, for example ZnN nanocrystals, which are a subgroup of the group II-III-N semiconductor nanocrystals. The composition and size of the new and novel II-III-N compound semiconductor nanocrystals can be controlled in order to tailor their band-gap and light emission properties. Efficient light emission in the ultraviolet-visible-infrared wavelength range is demonstrated.

Abstract: Antibodies which block binding of hPD-1 to hPD-L1 or hPD-L2 and their variable region sequences are disclosed. A method of increasing the activity (or reducing downmodulation) of an immune cell through the PD-1 pathway is also disclosed.

Abstract: To provide a television receiver, server, operation system for the television receiver, and operation program of the television receiver for enabling an operator to control the television receiver as intended without causing a conflict between user operation and operator operation without using a gateway, a television receiver 110 capable of being operated via a network has an operation instruction receiving section 112 that receives an operation instruction given via the network, an operation accepting section 111 that accepts operation that is directly given without via the network, a restriction determining section 113 that distinguishes between the operation based on the operation instruction received in the operation instruction receiving section 112 and the operation accepted in the operation accepting section 111 and that determines whether or not to restrict each operation, and a receiver-side control section 115 that executes control associated with the operation when the restriction determining sect

Abstract: The fixing apparatus is configured to include a fixing roller, a paper separation claw, a drive source that switches between a state in which the paper separation claw is in contact with the fixing roller and a state in which the paper separation claw is separated from the fixing roller, and a paper transport guide that is disposed on the downstream side of the fixing roller, the drive source including a heat generating element, and to further include a main ventilation channel that channels cooling air to a fixed paper sheet passing over the paper transport guide and a sub ventilation channel that is branched from the main ventilation channel and channels a portion of the cooling air to the heat generating element.

Abstract: A semiconductor device of the present invention includes an n-channel first thin film transistor and a p-channel second thin film transistor on one and the same substrate. The first thin film transistor has a first semiconductor layer (27), and the second thin film transistor has a second semiconductor layer (22). The first semiconductor layer (27) and the second semiconductor layer (22) are formed from one and the same film. Each of the first semiconductor layer (27) and the second semiconductor layer (22) has a slope portion (27e, 22e) positioned in the periphery and a main portion (27m, 22m) which is a portion excluding the slope portion. A p-type impurity is introduced into only a part of the slope portion (27e) of the first semiconductor layer with higher density than the main portion (27m) of the first semiconductor layer, the main portion (22m) of the second semiconductor layer, and the slope portion (22e) of the second semiconductor layer.

Abstract: The subject invention provides a drug delivery system comprising at least one compartment consisting of (i) a drug-loaded thermoplastic polymer core, (ii) a drug-loaded thermoplastic polymer intermediate layer and (iii) a non-medicated thermoplastic polymer skin covering the intermediate layer, wherein said intermediate layer is loaded with (a) crystals of a first pharmaceutically active compound and with (b) a second pharmaceutically active compound in dissolved form and wherein said core is loaded with said second compound in dissolved form.

Abstract: A flat panel display device includes a circuit board (110) that has formed thereon a plurality of power source lines (210) arranged in parallel, a power source bus (220) to which the plurality of power source lines (210) are connected, and a plurality of pixel circuits (240) each having an inner line path (66) connected to one of the power source lines (210). The display device also includes a plurality of light-emitting elements, each driven by a transistor provided in a corresponding one of pixel circuits (240). The inner line path (66) of each pixel circuit (240) provides a bypass path with respect to the power source line (210) connected thereto and part of the wiring for the transistor of the pixel circuit (240).

Abstract: In a radio communication system using OCC for DMRS, a base station apparatus correctly receives PUSCH.

Abstract: A backlight device 12 includes: a chassis having a bottom plate and side plates that stand towards the front of the bottom plate from the edges of the bottom plate, the face on one side of the bottom plate being a light-output part; an LED substrate disposed on the front surface of the bottom plate; LEDs 24 arranged on a plate face oriented toward the light-output part of the LED substrate and arranged so that the light-output part is on the light-emitting side thereof; a plurality of diffusion lenses 27 for covering the light-emitting side of the plurality of LEDs and diffusing the light from the LEDs 24; a first reflecting sheet 29 provided with light source insertion holes through which the LEDs 24 are inserted at positions corresponding to the LEDs 24, the first reflecting sheet being laid over the front surface of the bottom plate and over the LED substrate; and a second reflecting sheet 30 arranged so as to protrude in the direction in which the side plates rise, the ends of the second reflecting sheet

Abstract: A method of manufacturing a TFT substrate includes: forming a gate electrode (12) and a gate insulating film (30) on a substrate (8); forming a source electrode (14) and a drain electrode (15) at a gap from each other on the gate insulating film (30), and forming a drain connection part (16); forming, after the step of forming the source electrode and the drain electrode, an oxide semiconductor layer (18, 18a, 18b) that contains a channel portion connecting the source electrode (14) to the drain electrode (15) and that contains an additional portion (18a) covering the drain connection part (16); oxidizing a surface of the oxide semiconductor layer (18, 18a, 18b); forming a contact hole (22) in an insulating film (32) that covers the oxide semiconductor layer; removing a portion of the additional portion (18a) of the oxide semiconductor layer that is located inside the contact hole (22); and forming a conductive layer (20) that electrically connects the drain connection part (16) that has been exposed.

Abstract: The present invention includes: a heat dissipation plate (4) that has an upper surface on which an LED chip (3) is provided and that dissipates heat generated by the LED chip (3); a reflecting plate (7) for reflecting light emitted from the LED chip (3); and a substrate (2) provided between the heat dissipation plate (4) and the reflecting plate (7), the heat dissipation plate (4) and the reflecting plate (7) being integrally formed by bonding at a bonding section (12), the heat dissipation plate (4) and the substrate (2) being bonded to each other at a bonding section (20), the heat dissipation plate (4) and the reflecting plate (7) each having a surface covered by a conductor pattern (13).

Abstract: The invention is directed to compounds for selectively inhibiting glycosidases, uses of the compounds and pharmaceutical compositions including the compounds, and methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, and/or accumulation or deficiency of O-GlcNAc.

Abstract: A backlight unit includes a light source; a light guide; a gap retainer including two plate-like portions orthogonal to each other, the light guide being placed over a first plate-like portion of the two plate-like portions, the light source being attached to a side of a second plate-like portion of the two plate-like portions; a chassis including a frame-shaped side wall portion and a bottom portion, the gap retainer being positioned with respect to the chassis such that the second plate-like portion and the side wall portion face each other and the first plate-like portion and the bottom portion face each other; and an elastic body urging the gap retainer in a direction away from the side wall portion. The gap retainer includes a stopper to maintain a gap between the light source and the side edge surface of the light guide.

Abstract: The present invention relates to certain pyrazolo[1,5-a]pyrrolo[3,2-e]pyrimidine and dipyrazolopyrimidine compounds of Formula (I) as inhibitors of mammalian Target Of Rapamycin (mTOR) kinase, which is also known as FRAP, RAFT, RAPT or SEP. The compounds may be used in the treatment of cancer and other disorders where mTOR is deregulated. The present invention further provides pharmaceutical compositions comprising the pyrazolo[1,5-a]pyrrolo[3,2-e]pyrimidine or dipyrazolopyrimidine compounds.

Abstract: A semiconductor device (100a) with a thin-film transistor (10a) includes: a gate electrode (62) formed on a substrate (60); a gate insulating layer (66) formed on the gate electrode; an oxide semiconductor layer (68) formed on the gate insulating layer; source and drain electrodes (70s, 70d) electrically connected to the oxide semiconductor layer; a protective layer (72) formed on the oxide semiconductor layer and the source and drain electrodes; an oxygen supplying layer (74) formed on the protective layer; an anti-diffusion layer (78) formed on the oxygen supplying layer; and a transparent electrode (81) formed on the anti-diffusion layer and made of an amorphous transparent oxide.

Abstract: The present invention relates to substituted pyrimidines useful as HIF prolyl hydroxylase inhibitors to treat anemia and like conditions.

Abstract: Antibodies to human GITR are provided, as well as uses thereof, e.g., in treatment of proliferative and immune disorders.

Abstract: In order to enable suitable timing control of a display operation while simplifying a circuit configuration, a display device includes: an oscillation circuit 207 that oscillates a clock signal; a non-volatile memory 206 that stores values setting forth display operation timing of the display device in accordance with the clock signal; and a timing signal output circuit 209 that outputs timing signals controlling the display operation timing on the basis of pulse counts of the clock signal and the values stored in the non-volatile memory 206. The values stored in the non-volatile memory 206 correspond to deviations in oscillation frequency of the oscillation circuit 207 and deviations in delay of display operation from respective targets.

Abstract: The present invention is directed to imidazopyridin-2-one derivatives which are potentiators of metabotropic glutamate receptors, particularly the mGluR2 receptor, and which are useful in the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which metabotropic glutamate receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which metabotropic glutamate receptors are involved.

Abstract: In disparity-compensated prediction, the precision of prediction vectors is improved even if a prediction method different from disparity-compensated prediction is utilized for blocks around a block to be coded. An image coding apparatus (100) codes a plurality of viewpoint images captured from different viewpoints.